Identification of potential inhibitors of Leishmania donovani Sterol 24-C- methyltransferase: in silico and in vitro studies

References

• Karunaweera ND, Ferreira MU. Leishmaniasis: current challenges and prospects for elimination with special focus on the south Asian region. Parasitology. 2018;145(4):425–429. doi:10.1017/S0031182018000471.
   PubMed Web of Science ®Google Scholar
• Van Griensven J, Carrillo E, López-Vélez R, et al. Leishmaniasis in immunosuppressed individuals. Clinical Microbiology and Infection. 2014;20(4):286–299. doi:10.1111/1469-0691.12556.
   PubMed Web of Science ®Google Scholar
• Ghorbani M, Farhoudi R. Leishmaniasis in humans: drug or vaccine therapy? Drug Des Devel Ther. 2018;12:25–40. doi:10.2147/DDDT.S146521.
   PubMed Web of Science ®Google Scholar
• Singh OP, Singh B, Chakravarty J, et al. Current challenges in treatment options for visceral leishmaniasis in India: A public health perspective. Infect Dis Poverty. 2016 Mar 8;5:19. doi:10.1186/s40249-016-0112-2.
   PubMed Web of Science ®Google Scholar
• Sindermann H, Engel KR, Fischer C, et al.. ; Miltefosine Compassionate Use Program. Oral miltefosine for leishmaniasis in immunocompromised patients: compassionate use in 39 patients with HIV infection. Clin Infect Dis. 2004;39(10):1520–3. doi:10.1086/425359.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Das S, Kamran M, et al. The pathogenicity and virulence of Leishmania - interplay of virulence factors with host defenses. Virulence. 2022;13(1):903–935. doi:10.1080/21505594.2022.2074130.
   PubMed Web of Science ®Google Scholar
• He X, Zhang B, Tan H. Overexpression of a sterol C-24(28) reductase increases ergosterol production in Saccharomyces cerevisiae. Biotechnol Lett. 2003;25(10):773–8. doi:10.1023/a:1023572403185.
   PubMed Web of Science ®Google Scholar
• Chawla B, Madhubala R. Drug targets in Leishmania. J Parasit Dis. 2010;34(1):1–13. doi:10.1007/s12639-010-0006-3.
   PubMedGoogle Scholar
• de Souza W, Rodrigues JCF. Sterol biosynthesis pathway as target for anti-trypanosomatid drugs. Interdiscip Perspect Infect Dis. 2009;2009:642502. doi:10.1155/2009/642502.
   PubMedGoogle Scholar
• Viegas C, Da V, Bolzani S, et al. Os produtos naturais e a química medicinal moderna. Quim. Nova. 2006;29(2):326–337. doi:10.1590/S0100-40422006000200025.
   Google Scholar
• Winkel BSJ. The Biosynthesis of Flavonoids. In: Grotewold, E. (eds) The Science of Flavonoids. Springer, New York, NY. 2006. doi:10.1007/978-0-387-28822-2_3
   Google Scholar
• Ioset J-R. Natural products for neglected diseases: a review. Curr Org Chem. 2008;12(8):643– 666. doi:10.2174/138527208784577394.
   Web of Science ®Google Scholar
• Gervazoni LFO, Barcellos GB, Ferreira-Paes T, et al. Use of natural products in Leishmaniasis chemotherapy: an overview. Front Chem. Frontiers Media S.A. 2020;8:579891. doi:10.3389/fchem.2020.579891.
   Google Scholar
• Saha S, Mukherjee T, Chowdhury S, et al. The lignan glycosides lyoniside and saracoside poison the unusual type IB topoisomerase of Leishmania donovani and kill the parasite both in vitro and in vivo. Biochem Pharmacol. 2013;86(12):1673–87. doi:10.1016/j.bcp.2013.10.004.
   PubMed Web of Science ®Google Scholar
• Silva LG, Gomes KS, TA C-S, et al. Calanolides E1 and E2, two related coumarins from Calophyllum brasiliense Cambess. (Clusiaceae), displayed in vitro activity against amastigote forms of Trypanosoma cruzi and Leishmania infantum. Nat Prod Res. 2021;35(23):5373–5377. doi:10.1080/14786419.2020.1765347.
   PubMed Web of Science ®Google Scholar
• dos Santos Maia M, Silva JPR, de Lima Nunes TA, et al. Virtual screening and the in vitro assessment of the antileishmanial activity of lignans. Molecules. 2020;25(10):2281. doi:10.3390/molecules25102281.
   Web of Science ®Google Scholar
• Zhang Y. I-TASSER server for protein 3D structure prediction. BMC Bioinform. 2008;9:40. doi:10.1186/1471-2105-9-40.
   Web of Science ®Google Scholar
• Laskowski R, Macarthur BA, Thornton MW Computer programs PROCHECK: a program to check the stereochemicai quality of protein structures. Phys. Status Solidi B. 1983.
   Google Scholar
• Ansari WA, Rizvi F, Khan MA, et al.. Computational Study Reveals the Inhibitory Effects of Chemical Constituents from Azadirachta indica (Indian Neem) Against Delta and Omicron Variants of SARS-CoV-2. Coronaviruses. 2022;3 (5):e270822208065. doi:10.2174/2666796703666220827100054.
   Google Scholar
• Krieger E, Joo K, Lee J, et al. Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: four approaches that performed well in CASP8. Prot: Struct, Funct Bioinform. 2009;77 Suppl 9(Suppl 9):114–122. doi:10.1002/prot.22570.
   Web of Science ®Google Scholar
• Eisenberg D, Lothy R, Bowie JU.. VERIFY3D: assessment of protein models with three-dimensional profiles. Methods Enzymol. 1997;277:396–404. doi:10.1016/s0076-6879(97)77022-8.
   PubMed Web of Science ®Google Scholar
• Sievers F, Higgins DG. Clustal omega, accurate alignment of very large numbers of sequences. Methods in Molecular Biology. 2014;1079:105–116. doi:10.1007/978-1-62703-646-7_6.
   PubMedGoogle Scholar
• Tian W, Chen C, Lei X, et al. CASTp 3.0: computed atlas of surface topography of proteins. Nucleic Acids Res. 2018;46(W1):W363–W367. doi:10.1093/nar/gky473.
   PubMed Web of Science ®Google Scholar
• Lill MA, Danielson ML. Computer-aided drug design platform using PyMOL. J Comput Aided Mol Des. 2011;25(1):13–19. doi:10.1007/s10822-010-9395-8.
   PubMed Web of Science ®Google Scholar
• Trott O, Olson AJ. Autodock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2009;31(2):455–61. doi:10.1002/jcc.21334.
   Web of Science ®Google Scholar
• Wallace AC, Laskowski RA, Thornton JM. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions . Protein Eng. 1995;8(2):127–34. doi:10.1093/protein/8.2.127.
   PubMedGoogle Scholar
• Lipinski CA. Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol. 2004;1(4):337–341. doi:10.1016/j.ddtec.2004.11.007.
   PubMedGoogle Scholar
• Case DA, Cheatham Iii TE, Darden T, et al.. The Amber biomolecular simulation programs. J Comput Chem. 2005;26(16):1668–88. doi:10.1002/jcc.20290.
   PubMed Web of Science ®Google Scholar
• Jakalian A, Jack DB, Bayly CI. Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. parameterization and validation. Journal of Computational Chemistry. 2002;23(16):1623–1641. doi:10.1002/jcc.10128.
   PubMed Web of Science ®Google Scholar
• Sousa da Silva AW, Vranken WF.. ACPYPE - AnteChamber PYthon Parser interfacE. BMC Res Notes. 2012;5:367. doi:10.1186/1756-0500-5-367.
   PubMedGoogle Scholar
• Joung IS, Cheatham TE. Determination of alkali and halide monovalent ion parameters for use in explicitly solvated biomolecular simulations. Journal of Physical Chemistry B. 2008;112(30):9020–9041. doi:10.1021/jp8001614.
   PubMed Web of Science ®Google Scholar
• Pandey P, Prasad K, Prakash A, et al. Insights into the biased activity of dextromethorphan and haloperidol towards SARS-CoV-2 NSP6: in silico binding mechanistic analysis. J Mol Med. 2020;98(12):1659–1673. doi:10.1007/s00109-020-01980-1.
   PubMed Web of Science ®Google Scholar
• Kumar N, Srivastava R, Prakash A, et al. Virtual screening and free energy estimation for identifying mycobacterium tuberculosis flavoenzyme DprE1 inhibitors. J Mol Graph Model. 2021;102; 107770. doi:10.1016/j.jmgm.2020.107770.
   Web of Science ®Google Scholar
• Amadei A, Linssen AB, Berendsen HJ. Essential dynamics of proteins. PROTEINS: Structure, Function, and Genetics. 1993;17(4):412–25. doi:10.1002/prot.340170408.
   PubMed Web of Science ®Google Scholar
• David CC, Jacobs DJ. Principal component analysis: A method for determining the essential dynamics of proteins. Methods in Molecular Biology. 2014;1084:193–226. doi:10.1007/978-1-62703-658-0_11.
   PubMedGoogle Scholar
• Mishra CB, Shalini S, Gusain S, et al. Development of novel: N -(6-methanesulfonyl-benzothiazol-2-yl)-3-(4-substituted-piperazin-1-yl)-propionamides with cholinesterase inhibition, anti-β-amyloid aggregation, neuroprotection and cognition enhancing properties for the therapy of Alzheimer’s disease. RSC Adv. 2020;10:17602–17619. doi:10.1039/D0RA00663G.
   PubMed Web of Science ®Google Scholar
• Genheden S, Ryde U. The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov. 2015;10(5):449–461. doi:10.1517/17460441.2015.1032936.
   PubMed Web of Science ®Google Scholar
• Miller BR, McGee TD, Swails JM, et al. MMPBSA.py: An efficient program for end-state free energy calculations. J Chem Theory Comput. 2012;8(9):3314–3321. doi:10.1021/ct300418h.
   PubMed Web of Science ®Google Scholar
• van Meerloo J, Kaspers GJL, Cloos J.. Cell sensitivity assays: the MTT assay.. Methods Mol Biol. 2011;731:237–45. doi:10.1007/978-1-61779-080-5_20.
   PubMedGoogle Scholar
• Baranwal A, Chiranjivi AK, Kumar A, et al. Design of commercially comparable nanotherapeutic agent against human disease-causing parasite, Leishmania. Sci Rep. 2018;8(1):8814. doi:10.1038/s41598-018-27170-1.
   PubMedGoogle Scholar
• Rodina A, Godson GN. Role of conserved amino acids in the catalytic activity of Escherichia coli primase. J Bacteriol. 2006;188(10):3614–3621. doi:10.1128/JB.188.10.3614-3621.2006.
   PubMed Web of Science ®Google Scholar
• Geeganage S, Ling VW, Frey PA. Roles of two conserved amino acid residues in the active site of galactose-1-phosphate uridylyltransferase: An essential serine and a nonessential cysteine. Biochemistry. 2000;39(18):5397–5404. doi:10.1021/bi992594s.
   PubMed Web of Science ®Google Scholar
• Liu J, Ganapathy K, Wywial E, et al. Effect of substrate features and mutagenesis of active site tyrosine residues on the reaction course catalyzed by Trypanosoma brucei sterol C-24-methyltransferase. Biochemical Journal. 2011;439(3):413–428. doi:10.1042/BJ20110865.
   PubMedGoogle Scholar
• Broni E, Kwofie SK, Asiedu SO, et al. A molecular modeling approach to identify potential antileishmanial compounds against the cell division cycle (Cdc)-2-related kinase 12 (crk12) receptor of leishmania donovani. Biomolecules. 2021;11(3); 458. doi:10.3390/biom11030458.
   Web of Science ®Google Scholar
• Nisha CM, Kumar A, Nair P, et al. Molecular docking and in silico admet study reveals acylguanidine 7a as a potential inhibitor of β -secretase. Adv Bioinformatics. 2016;2016:9258578. doi:10.1155/2016/9258578.
   PubMedGoogle Scholar
• Kumar SP, Patel CN, Rawal RM, et al. Energetic contributions of amino acid residues and its cross-talk to delineate ligand-binding mechanism. Proteins. 2020;88(9):1207–1225. doi:10.1002/prot.25894.
   PubMed Web of Science ®Google Scholar
• Luthra PM, Prakash A, Barodia SK, et al. In silico study of naphtha [1, 2-d] thiazol-2-amine with adenosine A2A receptor and its role in antagonism of haloperidol-induced motor impairments in mice. Neurosci Lett. 2009;463(3):215–218. doi:10.1016/j.neulet.2009.07.085.
   PubMed Web of Science ®Google Scholar
• Garg A, Tewari R, Raghava GPS. Virtual screening of potential drug-like inhibitors against lysine/DAP pathway of mycobacterium tuberculosis. BMC Bioinform. 2010;11 Suppl 1(Suppl 1):S53. doi:10.1186/1471-2105-11-S1-S53.
   Web of Science ®Google Scholar
• Azam SS, Abbasi SW. Molecular docking studies for the identification of novel melatoninergic inhibitors for acetylserotonin-O-methyltransferase using different docking routines. Theor Biol Med Model. 2013;10:63. doi:10.1186/1742-4682-10-63.
   PubMed Web of Science ®Google Scholar
• Prakash A, Kumar V, Meena NK, et al. Elucidation of the structural stability and dynamics of heterogeneous intermediate ensembles in unfolding pathway of the N-terminal domain of TDP-43. RSC Adv. 2018;8:19835–19845. doi:10.1039/C8RA03368D.
   PubMed Web of Science ®Google Scholar
• Prakash A, Kumar V, Pandey P, et al. Solvent sensitivity of protein aggregation in Cu, Zn superoxide dismutase: a molecular dynamics simulation study. J Biomol Struct Dyn. 2018;36(10):2605–2617. doi:10.1080/07391102.2017.1364670.
   PubMed Web of Science ®Google Scholar
• Salehi B, Venditti A, Sharifi-Rad M, et al. The therapeutic potential of Apigenin. Int J Mol Sci. MDPI AG. 2019;20(6):1305. doi:10.3390/ijms20061305.
   PubMed Web of Science ®Google Scholar
• Naddaf N, Haddad S. Apigenin effect against Leishmania tropica amastigotes in vitro. Journal of Parasitic Diseases. 2020;44(3):574–578. doi:10.1007/s12639-020-01230-8.
   PubMedGoogle Scholar
• Tasdemir D, Kaiser M, Brun R, et al. Antitrypanosomal and antileishmanial activities of flavonoids and their analogues. In vitro, in vivo, structure-activity relationship, and quantitative structure-activity relationship studies. Antimicrob Agents Chemother. 2006;50(4):1352–1364. doi:10.1128/AAC.50.4.1352-1364.2006.
   PubMed Web of Science ®Google Scholar
• El-desoky AH, Abdel-Rahman RF, Ahmed OK, et al. Anti-inflammatory and antioxidant activities of naringin isolated from Carissa carandas L.: In vitro and in vivo evidence. Phytomedicine. 2018;42:126–134. doi:10.1016/j.phymed.2018.03.051.
   PubMed Web of Science ®Google Scholar
• Huwait E, Mobashir M. Potential and therapeutic roles of diosmin in human diseases. Biomedicines. 2022;10(5):1076. doi:10.3390/biomedicines10051076.
   PubMed Web of Science ®Google Scholar